FDA Approves Atezolizumab for Stage III dMMR Colon Cancer After Landmark ATOMIC Trial
The FDA has approved atezolizumab with chemotherapy for adjuvant treatment of stage III dMMR colon cancer after the phase III ...
Tag: atezolizumab
Gut Microbe Transplants May Reverse Immunotherapy Resistance in Liver Cancer
A phase II pilot trial found that a single fecal microbiota transplantation combined with atezolizumab and bevacizumab was safe and ...
One Dose of a New Immunotherapy Combo Triggered Four Organ Crises in a Lung Cancer Patient
A single cycle of atezolizumab plus tiragolumab triggered simultaneous myocarditis, hepatitis, thrombocytopenia, and dermatomyositis in a lung cancer patient, whose ...
Blood Cell Clues Reveal Who Benefits When Radiotherapy Meets Immunotherapy in Lung Cancer
A phase II trial of radiotherapy followed by atezolizumab in relapsed small cell lung cancer found that radiation-induced changes in ...
Radiation Supercharges Natural Killer Cell Therapy Against Liver Cancer in New Study
New research shows that radiation can make liver cancer cells more visible to natural killer cells, boosting the effectiveness of ...
AI Imaging Meets Flow Cytometry in Race to Detect Liver Cancer Cells in Blood
A Japanese team shows that AI-assisted imaging and flow cytometry count circulating tumor cells in liver cancer with strong agreement, ...
Immunotherapy Reshapes Advanced Liver Cancer Care in Europe, but Access Lags Behind
A major Lancet Regional Health – Europe review charts how combination immunotherapy transformed advanced hepatocellular carcinoma treatment while exposing stark ...
Radium-223 Therapy Lowers PD-L1 in Prostate Cancer Bone Metastases, PET Study Shows
A prospective imaging study shows that radium-223 significantly reduces PD-L1 expression and depletes immune cells in prostate cancer bone metastases, ...
Perioperative Immunotherapy More Than Doubles Event-Free Survival in Early-Stage Lung Cancer
Final Phase 3 IMpower030 results show that perioperative atezolizumab plus chemotherapy extended median event-free survival to 62.8 months versus 34.9 ...
PET Imaging Reveals Whether Immunotherapy Drugs Actually Reach Their Tumour Targets
Researchers are using PD-L1-targeted PET/CT imaging to directly visualise whether the immunotherapy drug atezolizumab saturates its target in tumours, offering ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!